Literature DB >> 21487771

Prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Albert Pahk1, Johanne Rigaux, Vijay Poreddy, Joan Smith, Firas Al-Kawas.   

Abstract

BACKGROUND AND AIMS: The ideal pancreatic stent to prevent post-ERCP pancreatitis (PEP) has yet to be determined. The aim of our study was to assess the relative benefit of 4-Fr versus 5-Fr stents in a population at high risk for post-ERCP pancreatitis, and the relative frequency of spontaneous migration. PATIENTS AND METHODS: All patients with prophylactic pancreatic stent (PPS) from 2002 to 2009 were reviewed. Patients were classified into two groups according to stent size and compared based on outcome; spontaneous migration or endoscopic removal.
RESULTS: A total of 346 PPS were placed in 308 patients (224 women, 84 men). The average age was 48.9 years. The most common indication for PPS was sphincter of Oddi dysfunction. Needle knife papillotomy was the most common procedure performed. Forty-seven patients had PEP, 4 Fr (14.6%) and 5 Fr (12.9%), with only one case of severe pancreatitis. Factors associated with higher rates PEP were younger age and pancreatic sphincterotomy. Complete follow-up was not available in 37 patients. Spontaneous migration was demonstrated in 115 of the 4 Fr (95.8%) and 134 of the 5 Fr (68.7%). The remaining 66 (five from the 4 Fr and 61 from the 5 Fr), were removed by endoscopy. The mean delay to demonstrate spontaneous migration was 34.2 days.
CONCLUSIONS: PPS in high-risk patients reduced the risk of post-ERCP pancreatitis and nearly eliminated severe pancreatitis. No significant difference between the 4 Fr and 5 Fr in reduction of post-ERCP pancreatitis was observed. However, spontaneous migration was more frequent with the 4-Fr stent.

Entities:  

Mesh:

Year:  2011        PMID: 21487771     DOI: 10.1007/s10620-011-1695-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  33 in total

1.  Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla.

Authors:  Gavin C Harewood; Nicole L Pochron; Christopher J Gostout
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

2.  Role of cytokines and their inhibitors in acute pancreatitis.

Authors:  A Kingsnorth
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones.

Authors:  T Aizawa; N Ueno
Journal:  Gastrointest Endosc       Date:  2001-08       Impact factor: 9.427

4.  Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.

Authors:  G Cavallini; A Tittobello; L Frulloni; E Masci; A Mariana; V Di Francesco
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

5.  Prophylaxis of post-ERCP pancreatitis: a practice survey.

Authors:  Jean-Marc Dumonceau; Johanne Rigaux; Michel Kahaleh; Carlos Macias Gomez; Alain Vandermeeren; Jacques Devière
Journal:  Gastrointest Endosc       Date:  2010-03-11       Impact factor: 9.427

6.  Risk factors for post-ERCP pancreatitis: a prospective multicenter study.

Authors:  Chi-Liang Cheng; Stuart Sherman; James L Watkins; Jeffrey Barnett; Martin Freeman; Joseph Geenen; Michael Ryan; Harrison Parker; James T Frakes; Evan L Fogel; William B Silverman; Kulwinder S Dua; Giuseppe Aliperti; Paul Yakshe; Michael Uzer; Whitney Jones; John Goff; Laura Lazzell-Pannell; Abdullah Rashdan; M'hamed Temkit; Glen A Lehman
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

7.  Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone.

Authors:  E L Fogel; D Eversman; P Jamidar; S Sherman; G A Lehman
Journal:  Endoscopy       Date:  2002-04       Impact factor: 10.093

Review 8.  Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Martin L Freeman
Journal:  Clin Gastroenterol Hepatol       Date:  2007-11       Impact factor: 11.382

9.  Significant clinical implications of prophylactic pancreatic stent placement in previously normal pancreatic ducts.

Authors:  Y G Bakman; K Safdar; M L Freeman
Journal:  Endoscopy       Date:  2009-11-10       Impact factor: 10.093

10.  Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.

Authors:  E Masci; A Mariani; S Curioni; P A Testoni
Journal:  Endoscopy       Date:  2003-10       Impact factor: 10.093

View more
  9 in total

1.  Letter in response to the recently published study: prophylactic pancreatic stents: does size matter? A comparison of 4-Fr and 5-Fr stents in reference to post-ERCP pancreatitis and migration rate.

Authors:  Prabhleen Chahal; Todd H Baron
Journal:  Dig Dis Sci       Date:  2012-04       Impact factor: 3.199

2.  The impact of prophylactic pancreatic stenting on post-ERCP pancreatitis: A nationwide, register-based study.

Authors:  Greger Olsson; Jeanne Lübbe; Urban Arnelo; Eduard Jonas; Björn Törnqvist; Lars Lundell; Lars Enochsson
Journal:  United European Gastroenterol J       Date:  2016-07-08       Impact factor: 4.623

3.  Complications of ERCP.

Authors:  Nalini M Guda; Duvvuru Nageshwar Reddy; Ajay Kumar
Journal:  Indian J Gastroenterol       Date:  2013-09-17

4.  Complications of endoscopic retrograde cholangiopancreatography: how to avoid and manage them.

Authors:  Nicholas M Szary; Firas H Al-Kawas
Journal:  Gastroenterol Hepatol (N Y)       Date:  2013-08

Review 5.  Prevention of post-ERCP pancreatitis.

Authors:  Jennifer Maranki; Paul Yeaton
Journal:  Curr Gastroenterol Rep       Date:  2013-11

6.  Triaging advanced GI endoscopy procedures during the COVID-19 pandemic: consensus recommendations using the Delphi method.

Authors:  Mandeep S Sawhney; Mohammad Bilal; Heiko Pohl; Vladimir M Kushnir; Mouen A Khashab; Allison R Schulman; Tyler M Berzin; Prabhleen Chahal; V Raman Muthusamy; Shyam Varadarajulu; Subhas Banerjee; Gregory G Ginsberg; Gottumukkala S Raju; Joseph D Feuerstein
Journal:  Gastrointest Endosc       Date:  2020-05-16       Impact factor: 9.427

7.  The feasibility of pancreatic duct stenting using a novel 4-Fr plastic stent with a 0.025-in. guidewire.

Authors:  Kazumasa Nagai; Atsushi Sofuni; Takayoshi Tsuchiya; Kentaro Ishii; Reina Tanaka; Ryosuke Tonozuka; Shuntaro Mukai; Kenjiro Yamamoto; Yukitoshi Matsunami; Yasutsugu Asai; Takashi Kurosawa; Hiroyuki Kojima; Hirohito Minami; Toshihiro Honma; Akio Katanuma; Takao Itoi
Journal:  Sci Rep       Date:  2021-07-12       Impact factor: 4.379

8.  Endoscopic retrieval technique of proximally migrated pancreatic stents: a retrospective study in a tertiary centre.

Authors:  Yi Lu; Zheng Jin; Jia-Chuan Wu; Li-Ke Bie; Biao Gong
Journal:  Gastroenterol Res Pract       Date:  2015-03-31       Impact factor: 2.260

9.  Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.

Authors:  Mitsuru Sugimoto; Tadayuki Takagi; Rei Suzuki; Naoki Konno; Hiroyuki Asama; Yuki Sato; Hiroki Irie; Ko Watanabe; Jun Nakamura; Hitomi Kikuchi; Yuichi Waragai; Mika Takasumi; Takuto Hikichi; Hiromasa Ohira
Journal:  World J Gastroenterol       Date:  2018-06-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.